Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug
Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug
Case Study:
Tailoring a Go-to-Market Strategy for a Prelaunch Biosimilar
This case study demonstrates how Magnolia Market Access helped a biopharma company optimize its go-to-market strategy for a biosimilar by analyzing payer segments and patient demographics.
Key highlights include:
- Challenge: Identify the payer and age mix for a biosimilar launch, understanding trends in an evolving insurance market.
- Approach:
- Analyzed three years of prescription drug data across retail, mail-order, and specialty pharmacies.
- Mapped payer channels, including commercial plans, Medicare, Medicaid, and patient assistance programs.
- Conducted interviews with payer decision-makers to assess coverage drivers like list price and rebates.
- Outcome: Magnolia developed a value proposition and payer strategy, addressing out-of-pocket costs and uninsured patient needs. Support resources tailored for patients, caregivers, and field teams were created to drive uptake and access.
Download the case study to explore how data-driven insights can refine biosimilar launch strategies.
